Cargando…
Pooling serum samples may lead to loss of potential biomarkers in SELDI-ToF MS proteomic profiling
BACKGROUND: High throughput proteomic technology offers promise for the detection of disease biomarkers and proteomic signature patterns but biomarker discovery studies can be limited by cost factors when large sample size numbers are required. Pooling sera or plasma samples from disease cases poten...
Autores principales: | Sadiq, S Tariq, Agranoff, Dan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2414484/ https://www.ncbi.nlm.nih.gov/pubmed/18513446 http://dx.doi.org/10.1186/1477-5956-6-16 |
Ejemplares similares
-
SELDI-TOF MS profiling of serum for detection of nasopharyngeal carcinoma
por: Huang, Yuan-Jiao, et al.
Publicado: (2009) -
SELDI-TOF-MS Proteomic Profiling of Serum, Urine, and Amniotic Fluid in Neural Tube Defects
por: Liu, Zhenjiang, et al.
Publicado: (2014) -
The Application of SELDI-TOF-MS in Clinical Diagnosis of Cancers
por: Liu, Chibo
Publicado: (2011) -
Limitations in SELDI-TOF MS whole serum proteomic profiling with IMAC surface to specifically detect colorectal cancer
por: Wang, Qi, et al.
Publicado: (2009) -
Proteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS
por: Van Gorp, Toon, et al.
Publicado: (2012)